features: Diagnosis

Nurses are indispensable component to the multidisciplinary team that cares for patients with myelodysplastic syndromes (MDS). As advances in the…

As the treatment of chronic lymphocytic leukemia (CLL) becomes increasingly genomics-driven, performing the appropriate genomic tests and utilizing these results…

As therapeutic strategies for chronic lymphocytic leukemia (CLL) increasingly consider the patients’ genomic landscape, implementing and interpreting appropriate tests is…

Nurses are indispensable component to the multidisciplinary team that cares for patients with myelodysplastic syndromes (MDS). As advances in the…

VJHemOnc is pleased to bring you a feature covering the current state of the field in the treatment CP-CML with…

VJHemOnc is excited to bring you the latest research updates in myeloid malignancies from the EHA 2022 Congress, which took…

Learn about the importance of performing genomic testing in CLL and how this impacts diagnosis, prognosis and treatment decisions.

VJHemOnc is excited to bring insights from Maria Victoria-Mateos and Irene Ghobrial, as discussed at the 18th International Myeloma Workshop…

A session with myelodysplastic syndromes (MDS) expert John Bennett who discusses MDS diagnosis and prognosis.

The U.S. Food and Drug Administration (FDA) has approved the first and only assay – clonoSEQ®, to screen and assess…

Published in Blood, a special report has proposed a new, distinct subtype of myelodysplastic syndromes (MDS) based on the presence…

The Video Journal of Hematological Oncology (VJHemOnc) is pleased to share the success of the PROMISE study by the Dana-Faber…

VJHemOnc is pleased to bring e-learning webcasts from iwNHL 2018- explore updates in lymphoma!